252 related articles for article (PubMed ID: 26452132)
21. Analysis of circulating extracellular vesicle-associated microRNAs in cortisol-producing adrenocortical tumors.
Perge P; Decmann Á; Pezzani R; Bancos I; Fassina A; Luconi M; Canu L; Tóth M; Boscaro M; Patócs A; Igaz P
Endocrine; 2018 Feb; 59(2):280-287. PubMed ID: 29299796
[TBL] [Abstract][Full Text] [Related]
22. Rottlerin as a novel chemotherapy agent for adrenocortical carcinoma.
Zhu Y; Wang M; Zhao X; Zhang L; Wu Y; Wang B; Hu W
Oncotarget; 2017 Apr; 8(14):22825-22834. PubMed ID: 28423559
[TBL] [Abstract][Full Text] [Related]
23. Preclinical assessment of synergistic efficacy of MELK and CDK inhibitors in adrenocortical cancer.
Laha D; Grant RRC; Mishra P; Boufraqech M; Shen M; Zhang YQ; Hall MD; Quezado M; De Melo MS; Del Rivero J; Zeiger M; Nilubol N
J Exp Clin Cancer Res; 2022 Sep; 41(1):282. PubMed ID: 36151566
[TBL] [Abstract][Full Text] [Related]
24. Integrated genome-wide analysis of genomic changes and gene regulation in human adrenocortical tissue samples.
Gara SK; Wang Y; Patel D; Liu-Chittenden Y; Jain M; Boufraqech M; Zhang L; Meltzer PS; Kebebew E
Nucleic Acids Res; 2015 Oct; 43(19):9327-39. PubMed ID: 26446994
[TBL] [Abstract][Full Text] [Related]
25. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
26. [Pathogenic and diagnostic roles of microRNAs in adrenocortical tumours].
Nagy Z; Decmann Á; Perge P; Igaz P
Orv Hetil; 2018 Feb; 159(7):245-251. PubMed ID: 29429354
[TBL] [Abstract][Full Text] [Related]
27. Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b.
Kim JK; Noh JH; Jung KH; Eun JW; Bae HJ; Kim MG; Chang YG; Shen Q; Park WS; Lee JY; Borlak J; Nam SW
Hepatology; 2013 Mar; 57(3):1055-67. PubMed ID: 23079745
[TBL] [Abstract][Full Text] [Related]
28. MiR-486-3p was downregulated at microRNA profiling of adrenals of multiple endocrine neoplasia type 1 mice, and inhibited human adrenocortical carcinoma cell lines.
Li SC; Monazzam A; Razmara M; Chu X; Stålberg P; Skogseid B
Sci Rep; 2021 Jul; 11(1):14772. PubMed ID: 34285285
[TBL] [Abstract][Full Text] [Related]
29. Adrenocortical carcinoma: review of the pathologic features, production of adrenal steroids, and molecular pathogenesis.
Nakamura Y; Yamazaki Y; Felizola SJ; Ise K; Morimoto R; Satoh F; Arai Y; Sasano H
Endocrinol Metab Clin North Am; 2015 Jun; 44(2):399-410. PubMed ID: 26038208
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA miR-302 inhibits the tumorigenicity of endometrial cancer cells by suppression of Cyclin D1 and CDK1.
Yan GJ; Yu F; Wang B; Zhou HJ; Ge QY; Su J; Hu YL; Sun HX; Ding LJ
Cancer Lett; 2014 Apr; 345(1):39-47. PubMed ID: 24333727
[TBL] [Abstract][Full Text] [Related]
31. Regulation of insulin-like growth factor-mammalian target of rapamycin signaling by microRNA in childhood adrenocortical tumors.
Doghman M; El Wakil A; Cardinaud B; Thomas E; Wang J; Zhao W; Peralta-Del Valle MH; Figueiredo BC; Zambetti GP; Lalli E
Cancer Res; 2010 Jun; 70(11):4666-75. PubMed ID: 20484036
[TBL] [Abstract][Full Text] [Related]
32. The underlying molecular mechanism and drugs for treatment in adrenal cortical carcinoma.
Ma C; Xiong J; Su H; Li H
Int J Med Sci; 2021; 18(13):3026-3038. PubMed ID: 34220331
[No Abstract] [Full Text] [Related]
33. Assessment and management of advanced adrenocortical carcinoma using a precision oncology care model.
Elfiky AA; Krishnan Nair HK
Discov Med; 2016 Jan; 21(113):49-56. PubMed ID: 26896602
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma.
Fang Y; Xue JL; Shen Q; Chen J; Tian L
Hepatology; 2012 Jun; 55(6):1852-62. PubMed ID: 22234835
[TBL] [Abstract][Full Text] [Related]
35. n-3 polyunsaturated fatty acids abrogate mTORC1/2 signaling and inhibit adrenocortical carcinoma growth in vitro and in vivo.
Liu J; Xu M; Zhao Y; Ao C; Wu Y; Chen Z; Wang B; Bai X; Li M; Hu W
Oncol Rep; 2016 Jun; 35(6):3514-22. PubMed ID: 27035283
[TBL] [Abstract][Full Text] [Related]
36. Systematic analysis of the BET family in adrenocortical carcinoma: The expression, prognosis, gene regulation network, and regulation targets.
Situ Y; Liang Q; Zeng Z; Chen J; Shao Z; Xu Q; Lu X; Cui Y; Zhang J; Lu L; Deng L
Front Endocrinol (Lausanne); 2023; 14():1089531. PubMed ID: 36793283
[TBL] [Abstract][Full Text] [Related]
37. Next-generation sequencing reveals microRNA markers of adrenocortical tumors malignancy.
Koperski Ł; Kotlarek M; Świerniak M; Kolanowska M; Kubiak A; Górnicka B; Jażdżewski K; Wójcicka A
Oncotarget; 2017 Jul; 8(30):49191-49200. PubMed ID: 28423361
[TBL] [Abstract][Full Text] [Related]
38. MicroRNAs and Long Non-Coding RNAs in Adrenocortical Carcinoma.
Detomas M; Pivonello C; Pellegrini B; Landwehr LS; Sbiera S; Pivonello R; Ronchi CL; Colao A; Altieri B; De Martino MC
Cells; 2022 Jul; 11(14):. PubMed ID: 35883677
[TBL] [Abstract][Full Text] [Related]
39. The potential role of miRNAs in the pathogenesis of adrenocortical carcinoma - A focus on signaling pathways interplay.
Midan HM; Helal GK; Abulsoud AI; Elshaer SS; El-Husseiny AA; Fathi D; Abdelmaksoud NM; Abdel Mageed SS; Elballal MS; Zaki MB; Abd-Elmawla MA; Al-Noshokaty TM; Rizk NI; Elrebehy MA; El-Dakroury WA; Hashem AH; Doghish AS
Pathol Res Pract; 2023 Aug; 248():154690. PubMed ID: 37473498
[TBL] [Abstract][Full Text] [Related]
40. 2D-DIGE proteomic analysis identifies new potential therapeutic targets for adrenocortical carcinoma.
Poli G; Ceni E; Armignacco R; Ercolino T; Canu L; Baroni G; Nesi G; Galli A; Mannelli M; Luconi M
Oncotarget; 2015 Mar; 6(8):5695-706. PubMed ID: 25691058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
